Drugs Made In America Acquisition Corp. (DMAA)
10.45
+0.02
(+0.19%)
USD |
NASDAQ |
Feb 20, 16:00
Drugs Made In America Acquisition EPS Diluted (Quarterly) : 0.0652 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Innovaro, Inc. | 0.00 |
| National Graphite Corp. | -- |
| MoneyOnMobile, Inc. | -- |
| Emo Capital Corp. | -- |
| Crescent Capital BDC, Inc. | 0.1916 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.185M |
| Total Expenses (Quarterly) | -2.185M |
| Enterprise Value | 350.25M |
| Earnings Yield | 1.61% |
| Normalized Earnings Yield | 1.612 |